Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16237114 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Vaccine Therapy in Treating Patients With Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: aldesleukin;   Biological: gp100 antigen;   Biological: incomplete Freund's adjuvant;   Biological: tyrosinase peptide

Indicates status has not been verified in more than two years